SCYNEXIS Inc. (SCYX)
SCYX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.99
-0.99% on the day
Market cap
$39.7M
Nano cap
Revenue · 2025
$20.6M
+449.9% on 2024
Net income · 2025
-$8.6M
-41.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SCYX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001178253 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DELAWARE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $20.6M |
| Net income | -$8.6M |
| Operating income | -$16.1M |
| Net margin | -41.8% |
| Operating margin | -78.0% |
| Revenue growth | +449.9% |
| Cash | $21.3M |
| Total assets | $59.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-05-08 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 742 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EDSA | Edesa Biotech Inc. Common Shares | $2.85 | -3.23% | $38.4M |
| GRCE | Grace Therapeutics Inc. | $1.99 | -1.49% | $41.9M |
| VERU | Veru Inc. | $2.19 | -8.94% | $37.3M |
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
| LITS | Lite Strategy Inc. | $1.21 | -0.82% | $36.8M |
| IXHL | Incannex Healthcare Inc. | $2.91 | +0.34% | $36.5M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
| DWTX | Dogwood Therapeutics Inc. | $1.30 | -5.11% | $44.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier